Ultraviolet B efficacy in improving antileishmanial effects of silver nanoparticles

Document Type: Original Article


1 Department of Medical Physics, Hormozgan University of Medical Sciences, Bandar Abbas, Iran

2 Research Center for Skin Diseases and Cutaneous Leishmaniasis, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

3 Research Center of Medicinal Chemistry, Mashhad University of Medical Sciences, Mashhad, Iran

4 Medical Physics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran


Objective(s):Cutaneous Leishmaniasis (CL) is a parasitic disease caused by various species of the flagellated protozoan, Leishmania. Regardless of the numerous studies, there are still serious challenges in the treatment of CL. This study aimed at evaluating the influence of a low dose ultraviolet B (UVB) radiation along with silver nanoparticles (AgNPs) on a mouse model of CL induced by Leishmania major[m1] .
Materials and Methods: L. major promastigotes (MRHO/IR/75/ER) were extracted from infected mice spleens. Two months after subcutaneous injection of 2×106 promastigotes into the footpad of BALB/c mice, when the lesions were developed, the animals were divided into 4 groups including one control group and three study groups: AgNPs, UVB and UVB plus AgNPs. Spleen parasite burden was assessed on day 40 after the first treatment. The data were analyzed by Instat, Elidaand SPSS16 software programs.
Results:  The results showed the highest pronounced inhibitory effect in the group receiving AgNPs plus UVB. In addition, a significant difference was obtained between the group receiving AgNPs alone and the one with combinational therapy. The findings on parasite burden showed a significant difference between the control group and other treatment groups.
Conclusion:It could be suggested that UVB in the presence of AgNPs, by inhibiting the spread of CL lesions and reducing the rate of visceral progression of the disease, provides a serious anti-leishmanial effect.



1.Igbineweka O, Aghedo F, Idusuyi O, Hussain N. Evaluating the efficacy of topical silver nitrate and intramuscular antimonial drugs in the treatment of cutaneous leishmaniasis in sokoto, Nigeria. Afr J Clin Exp Microbiol 2012; 13:90-97.

2.Sazgarnia A, Zabolinejad N, Layegh P, Rajabi O, Berenji F, Javidi Z, et al. Antileishmanial activity of liposomal clarithromycin against Leishmania major Promastigotes. Iran J Basic Med Sci 2012; 15:1210-1214.

3.Sazgarnia A, Taheri AR, Soudmand S, Parizi AJ, Rajabi O, Darbandi MS. Antiparasitic effects of gold nanoparticles with microwave radiation on promastigots and amastigotes of Leishmania major. Int J Hyperthermia 2013; 29:79-86.

4.Kvítek L, Panacek A, Prucek R, Soukupova J, Vanickova M, Kolar M, et al. editors. Antibacterial activity and toxicity of silver–nanosilver versus ionic silver. IOP Publishing;2011.

5.Darroudi M, Ahmad MB, Shameli K, Abdullah AH, Ibrahim NA. Synthesis and characterization of UV-irradiated silver/montmorillonite nanocomposites. Solid State Sci 2009; 11:1621-1624.

6.Kheybari S, Samadi N, Hosseini SV, Fazeli A, Fazeli MR. Synthesis and antimicrobial effects of silver nanoparticles produced by chemical reduction method. DARU 2010; 18:168-172.

7.Khosravi A, Sharifi I, Barati M, Zarean M, Hakimi-Parizi M. Anti-leishmanial effect of nanosilver solutions on Leishmania tropica promastigotes by in-vitro assay. ZJRMS 2011; 13:8-12.

8.Torabi T ,Mohebali M, Shahverdi AR, Rezayat SM, Edrissian GH, Esmaeili J, et al. Nanogold for the treatment of zoonotic cutaneous leishmaniasis caused by Leishmania major (MRHO/IR/75/ER):An animal trial with methanol extract of Eucalyptus camaldulensis.JPHS 2011; 1:15-18.

9.Ghorbanzadeh V, Moshtaghian SJ, Habibian S, Ebadi AG. Influence of nano-silver on graffian follicles via intraperitoneal injection in rats. Middle East J Sci Res 2011; 8:228-230.

10.Pastila R. Effects of ultraviolet radiation on skin cell proteome. Ad Exp Med Biol 2013; 990:121-127.

11.El-Zawahry BM, Bassiouny DA, Sobhi RM, Abdel-Aziz E, Zaki NS, Habib DF, et al. A comparative              study on efficacy of UVA1 vs. narrow-band UVB phototherapy in the treatment of vitiligo. Photodermatol Photoimmunol Photomed 2012; 28:84-90.

12.Evers AW, Kleinpenning MM, Smits T, Boezeman J, van de Kerkhof PC, Kraaimaat FW, et al. Treatment nonadherence and long-term effects of narrowband UV-B therapy in patients with psoriasis. Arch Dermatol 2010; 146:198-199.

13.Giannini M. Suppression of pathogenesis in cutaneous leishmaniasis by UV irradiation. Infect Immun 1986; 51:838-843.

14.Allahverdiyev AM, Abamor ES, Bagirova M, Ustundag CB, Kaya C, Kaya F, et al. Antileishmanial effect of silver nanoparticles and their enhanced antiparasitic activity under ultraviolet light. Int J Nanomed 2011; 6:2705-2714.

15.Khaskhely NM, Maruno M, Uezato H, Takamiyagi A, Ramzi ST, Al-Kasem KM, et al. Low-dose UVB contributes to host resistance against Leishmania amazonensis infection in mice through induction of gamma interferon and tumor necrosis factor alpha cytokines. Clin Diagnost Lab Immun 2002; 9:677-686.

16.Giannini SH. Effects of ultraviolet  B  irradiation  on cutaneous  leishmaniasis. Parasitol Today 1992; 2:44-48.

17.Yadegari-Dehkordi S, Sadeghi HR, Attaran-Kakhki N, Shokouhi M, Sazgarnia A. Silver nanoparticles increase cytotoxicity induced by intermediate frequency low voltages. Electromagn Biol Med 2014; 5:1-5.

18.Mohebali M, Rezayat MM, Gilani K, Sarkar S, Akhoundi B, Esmaeili J, et al. Nanosilver in the treatment of localized cutaneous leishmaniasis caused by Leishmania major (MRHO/IR/75/ER): an in vitro and in vivo study.DARU  2009;4:285-289.

19.Ehrchen J, Sindrilaru A, Grabbe S, Schlesiger C, Sorg C, Scharffetter-Kochanek K, et al. Senescent BALB/c mice are able to develop resistance to Leishmania major infection. Infect Immun 2004; 72:5106–5114.

20.Honigsmann HST, Bolognia J, Jorizzo JL, Rapini RP. Ultraviolet Therapy In Dermatology. New York: Mosby; 2012.

21.Zanolli MD FS, Clark AR, Fleischer AB Jr.  Phototherapy Treatment Protocols: For Psoriasis and Other Phototherapy Responsive Dermatoses. Parthenon Publishing; 2000.

22. Xue Y, Zhang S, Huang Y, Zhang T, Liu X, Hu Y, et al. Acute toxic effects and gender-related biokinetics of silver nanoparticles following an intravenous injection in mice. J Appl Toxicol 2012; 32:890-899.

23.Buffet P, Sulahian A, Garin Y, Nassar N, Derouin F. Culture microtitration: a sensitive method for quantifying Leishmania infantum in tissues of infected mice. Antimicrob Agents Chemother 1995; 39:2167-2168.

24.Damian DL, Barnetson RS, Halliday GM. Effects of low-dose ultraviolet radiation on in vivo human cutaneous recall responses. Austr J Dermatol 2001; 42:161-167.

25.Darroudi M, Ahmad MB, Zak AK, Zamiri R, Hakimi M. Fabrication and characterization of gelatin stabilized silver nanoparticles under UV-light. Int J Mol Sci 2011; 12:6346-6356.

26.Hockberger PE. A history of ultraviolet photobiology for humans, animals and microorganisms. Photochem Photobiol 2002; 76:561-579.

27.Moreira Nd, Vitoriano-Souza J, Roatt BM, Vieira PM, Ker HG, de Oliveira Cardoso JM, et al.  Parasite burden in hamsters infected with two different strains of leishmania (Leishmania) infantum: “Leishman Donovan Units” versus real-time PCR. PLoS One 2012; 7:2012.